Figure 5

Significantly lower SI ratio of Bis-5HT-DTPA enhancement in cortex, hippocampus and thalamus in the group treated with tacrolimus compared to the control group without anti-inflammatory treatment. Quantitative analysis of Bis-5HT-DTPA enhancement by comparing signal intensity (SI) ratio between the ischemic region and the contralateral ROI mirrored along the midline of the group treated with tacrolimus and the control group (n = 5, each group) in cortex, hippocampus and thalamus (graph shows median, **P = 0.008 and *P = 0.016).